Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression

Journal of Affective Disorders

Volumn 111, Issue 1, 2008, Pages 106-112

  Bosmans, Judith E ^a,b   Hermens, Marleen L M ^c   de Bruijne, Martine C ^a   van Hout, Hein P J ^c   Terluin, Berend ^c   Bouter, Lex M ^a   Stalman, Wim A B ^c   van Tulder, Maurits W ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Faculty of Earth and Life Sciences   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antidepressive agents; Costs and cost analysis; Depressive disorder; Primary health care

Indexed keywords

ANTIDEPRESSANT AGENT; PAROXETINE;

ADULT; ARTICLE; BOOTSTRAPPING METHOD; CONFIDENCE INTERVAL; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISEASE SEVERITY; ECONOMIC EVALUATION; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; TECHNIQUE;

ANTIDEPRESSIVE AGENTS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DRUG COSTS; FAMILY PRACTICE; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUALITY-ADJUSTED LIFE YEARS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 52149117590     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.02.002     Document Type: Article

References (30)

1. Ackermann R.T., and Williams Jr. J.W. Rational treatment choices for non-major depressions in primary care: an evidence-based review. J. Gen. Intern. Med. 17 (2002) 293-301
2. Altman D.G., and Bland J.M. Absence of evidence is not evidence of absence. BMJ 311 (1995) 485
3. Black W.C. The CE plane: a graphic representation of cost-effectiveness. Med. Decis. Making 10 (1990) 212-214
4. Briggs A. Economic evaluation and clinical trials: size matters. BMJ 321 (2000) 1362-1363
5. Broadhead W.E., Blazer D.G., George L.K., and Tse C.K. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 264 (1990) 2524-2528
6. Chaudhary M.A., and Stearns S.C. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat. Med. 15 (1996) 1447-1458
7. Dolan P. Modeling valuations for EuroQol health states. Med. Care. 35 (1997) 1095-1108
8. Efron B., and Tibshirani R.J. An Introduction to the Bootstrap (1993), Chapman & Hall, New York
9. Elkin I., Shea M.T., Watkins J.T., Imber S.D., Sotsky S.M., Collins J.F., Glass D.R., Pilkonis P.A., Leber W.R., and Docherty J.P. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch. Gen. Psychiatry 46 (1989) 971-982
10. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16 (1990) 199-208
11. Hermens M.L., van Hout H.P., Terluin B., Ader H.J., Penninx B.W., van Marwijk H.W., Bosmans J.E., van Dyck R., and De Haan M. Clinical effectiveness of usual care with or without antidepressant medication for primary care patients with minor or mild-major depression: a randomized equivalence trial. BMC Med. 5 (2007) 36
12. Johnson J., Weissman M.M., and Klerman G.L. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 267 (1992) 1478-1483
13. Jones B., Jarvis P., Lewis J.A., and Ebbutt A.F. Trials to assess equivalence: the importance of rigorous methods. BMJ 313 (1996) 36-39
14. Katon W., and Schulberg H. Epidemiology of depression in primary care. Gen. Hosp. Psychiatry 14 (1992) 237-247
15. Kessler R.C., Barber C., Birnbaum H.G., Frank R.G., Greenberg P.E., Rose R.M., Simon G.E., and Wang P. Depression in the workplace: effects on short-term disability. Health Aff. 18 (1999) 163-171
16. Koopmanschap M.A., and Rutten F.F. A practical guide for calculating indirect costs of disease. Pharmacoeconomics 10 (1996) 460-466
17. Lave J.R., Frank R.G., Schulberg H.C., and Kamlet M.S. Cost-effectiveness of treatments for major depression in primary care practice. Arch. Gen. Psychiatry 55 (1998) 645-651
18. Luber M.P., Hollenberg J.P., Williams-Russo P., DiDomenico T.N., Meyers B.S., Alexopoulos G.S., and Charlson M.E. Diagnosis, treatment, comorbidity, and resource utilization of depressed patients in a general medical practice. Int. J. Psychiatry Med. 30 (2000) 1-13
19. MacGillivray S., Arroll B., Hatcher S., Ogston S., Reid I., Sullivan F., Williams B., and Crombie I. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ 326 (2003) 1014
20. Malt U.F., Robak O.H., Madsbu H.P., Bakke O., and Loeb M. The Norwegian naturalistic treatment study of depression in general practice (NORDEP)-I: randomised double blind study. BMJ 318 (1999) 1180-1184
21. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
22. Oostenbrink J.B., Koopmanschap M.A., and Van Rutten F.F.H. The Hague (2000), Health Care Insurance Council, The Netherlands
23. Oostenbrink J.B., Koopmanschap M.A., and Rutten F.F. Standardisation of costs: the Dutch Manual for Costing in economic evaluations. Pharmacoeconomics 20 (2002) 443-454
24. Spies T., Mokkink H., De Vries Robbé P., and Grol R. Huisarts kiest vaak voor antidepressiva onafhankelijk van de ernst van de depressie. Huisarts Wet 47 (2004) 364-367
25. SPSS Inc. SPSS 10.1 (2000), SPSS Inc, Chicago, IL
26. Statistics Netherlands, 2007. www.cbs.nl (Accessed January, 2008).
27. van Marwijk H.W.J., Grundmeijer H.G.L.M., Brueren M.M., Sigling H.O., Stolk J., van Gelderen M.G., Vintges M., Eizenga W.H., and Burgers J.S. Guidelines on Depression of the Dutch College of General Practitioners (NHG-Standaard Depressie). Huisarts Wet 37 (1994) 482-490
28. van Marwijk H.W., Bijl D., Ader H.J., and De Haan M. Antidepressant prescription for depression in general practice in The Netherlands. Pharm.World Sci. 23 (2001) 46-49
29. Wells K.B., Stewart A., Hays R.D., Burnam M.A., Rogers W., Daniels M., Berry S., Greenfield S., and Ware J. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 262 (1989) 914-919
30. Z-index. The Hague (2002), Z-index, The Netherlands